FDA NDC Directory · JSON-LD · Markdown

Cilostazol

NDC 0093-2065 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerTeva Pharmaceuticals USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA077027
Dosage form / routeTABLET · ORAL
Active ingredientsCILOSTAZOL (50 mg/1)
Marketing started20120424
Package count1

External sources

Source: openFDA. Public-domain (CC0).